Navigation Links
Researchers at Scripps to Study Possible New Treatment for Parkinson's Disease
Date:1/25/2013

SAN DIEGO, Jan. 25, 2013 /PRNewswire/ -- Scripps Clinic, in partnership with The Scripps Research Institute (TSRI), has begun the research phase of a proposed clinical trial using induced pluripotent stem cells to halt or reverse the effects of Parkinson's disease.

(Logo: http://photos.prnewswire.com/prnh/20121018/LA95241LOGO)

Under the leadership of Melissa Houser, MD, neurologist and medical director of Scripps Clinic's Parkinson's Disease and Movement Disorders Center, and co-investigator Jeanne F. Loring, PhD, professor and director of the Center for Regenerative Medicine at TSRI, skin cells taken from Parkinson's disease patients who meet select criteria are being cultivated in vitro and turned into pluripotent stem cells. These stem cells will be developed into dopamine-producing brain cells.

The plans, which will require Food and Drug Administration (FDA) approval, are to implant these cells back into the donor patients' brains; the goal is for the cells to integrate inside the brain and produce enough dopamine to alleviate the worst symptoms of Parkinson's disease. There are currently several clinical trials using pluripotent stem cells to replace cells lost to injury or neurodegenerative disease, as well as for the development of pharmaceuticals, but reimplantation of cells into the same patient for function restoration as a treatment for Parkinson's disease has never been attempted.  

"What sets our study apart from many others is that it's patient-specific," said Dr. Houser. "That means our patients who initially donated their skin cells will eventually receive their own cells again, with their own DNA, just in a different form. Our hope is that this will slow or stop the progression of Parkinson's disease while minimizing the potential for rejection."

Pluripotent stem cells

Stem cells are unspecialized cells that can regenerate and can be directed to convert into specific tissue or organ cells with specialized functions.

"The word 'pluripotent' means that the cells can turn into any other kind of cell," said Dr. Loring. "We're converting adult cells taken from skin samples into pluripotent stem cells. These simple skin cells are now in the middle of a remarkable journey toward becoming nerve cells, and we're excited to explore their use as a viable treatment for Parkinson's disease."

Preliminary research will likely be completed in 2013. That stage will be followed by preparation of the cells for clinical use when the group plans to join other qualified organizations to help design a national, multicenter trial. The clinical trial is slated to launch two or three years later, depending on the timeframe required for obtaining FDA and other regulatory approvals.

Parkinson's disease symptoms and treatment

Healthy nerve cells in our brains produce molecules called neurotransmitters, including dopamine, which is a chemical that helps control muscle movement. In Parkinson's disease, nerve cells degenerate, and the resulting loss of dopamine leads to symptoms that include muscle tremor, muscle stiffness, trouble walking, imbalance and speech problems.

While Parkinson's disease itself is technically not fatal, the Centers for Disease Control and Prevention rated complications from the disease as the 14th leading cause of death in the United States; it is estimated to affect one in 100 people over age 60. While medications and surgery can be helpful in lessening symptoms, there is not currently a cure for Parkinson's disease.

ABOUT THE SCRIPPS RESEARCH INSTITUTE

The Scripps Research Institute is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. Over the past decades, TSRI has developed a lengthy track record of major contributions to science and health, including laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. The institute employs about 3,000 people on its campuses in La Jolla, Calif., and Jupiter, Fla., where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top 10 of its kind in the nation. For more information, see www.scripps.edu.

ABOUT SCRIPPS HEALTH

Founded in 1924 by philanthropist Ellen Browning Scripps , Scripps Health is a $2.6 billion nonprofit integrated health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 13,500 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of physician offices and 23 outpatient centers and clinics.

Recognized as a leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research, genomic medicine, wireless health care and graduate medical education. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges and is recognized by Thomson Reuters for having one of the top teaching hospitals in the nation. Scripps is also the region's only cardiovascular program recognized by U.S. News & World Report as one of the best in the country. Scripps has been consistently recognized by Fortune, Working Mother magazine and AARP as one of the best places in the nation to work. More information can be found at www.scripps.org.


'/>"/>
SOURCE Scripps Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
2. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
3. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
4. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
5. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
6. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
7. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
8. Researchers Set Record for Detecting Smallest Virus, Opening New Possibilities for Early Disease Detection
9. Researchers and Patient Advocates Honored with PhRMA Award
10. Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research
11. As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... a major "team investment" by Bruce Montgomery , one of this area,s most prominent biotech ... Leen Kawas , PhD. Photo - ... ... ... Kawas said the round was intended to be an $8 ...
(Date:2/11/2016)... , Feb. 11, 2016  AcelRx Pharmaceuticals, Inc. ... presentation will be made at the 38th annual ... Wound Care Symposium, which is being held February 14-18, ... conference covers the latest advancements in wound healing, burn ... American Burn Association, Australian-New Zealand Burns Association, Academy of ...
(Date:2/11/2016)... TEL AVIV, Israel , Feb. 11, 2016  Galmed ... clinical-stage biopharmaceutical company focused on the development of a ... announced today that its Chief Medical Officer, Dr. ... retiring from Galmed as Chief Medical Officer and from ... 2016 due to her reaching retirement age. ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Sherly Sulaiman, certified ... series of therapeutic sessions to help Los Angeles-area actors cope with rejection, improve ... The series, known as “Mindfulness for Actors and Artists,” has been featured in ...
(Date:2/10/2016)... , ... February 10, 2016 , ... LaserShip, a regional ... to the Food Bank of Eastern Michigan last Friday in order to aid in ... into the Midwest to include a facility located in Clio, only 15 miles away ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... to expand dental health services to the developmentally disabled in the Coachella Valley. ... operations to a new facility at 71-949 Highway 111, Suite 100-B, in Rancho ...
(Date:2/10/2016)... ... 10, 2016 , ... As part of its ongoing series of aquatic therapy ... webinar features a dynamic expert and thoughtful presentation to give attendees a better sense ... Both events are free to attend, but registration is required. , Rehabilitation ...
(Date:2/10/2016)... ... 10, 2016 , ... Intermedix announced on Wednesday that it ... emergency medicine professional association, to support the organization's newly established physician group with ... Emergency Medicine, or AAEM, seeks to empower emergency physicians to control their own ...
Breaking Medicine News(10 mins):